about
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort.Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Probiotics in infective diarrhoea and inflammatory bowel diseases.Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome.Management of pouch dysfunction or pouchitis with an ileoanal pouch.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.Role of conventional therapies in the era of biological treatment in Crohn's disease.Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study.Diagnosis and treatment of pouchitis.Probiotics for the treatment of postoperative complications following intestinal surgery.Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease.Management of inflammatory bowel disease: does rifaximin offer any promise?VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.Antimicrobials in the management of inflammatory bowel disease.Review article: aminosalicylates for distal colitis.Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosisSecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.The role of Budesonide-MMX in active ulcerative colitis.Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.European evidence based consensus on surgery for ulcerative colitis.Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis.Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study.Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.The effect of transient intestinal ischemia on inflammatory parameters.Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease.High-dose probiotics for the treatment of active pouchitis.Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls.Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon.The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.
P50
Q30581062-7103D518-6A80-4948-9D95-9E70ACA3ED48Q30778152-40C870BA-DE71-4E90-9947-7E59CA087EE9Q33231186-2B44274F-7D4A-4727-B0B7-A74EE9FF4359Q33939743-35BCD09D-48B1-4C72-813E-4ECB8A4C5884Q34504027-FF7BCC25-EE1A-4ED7-9554-9A56CD274BC9Q34528521-934232DB-1475-4E81-8B8A-E927C272876FQ34551989-5A8423D6-F5D7-4E55-BBD7-47CEEAE32D3BQ34564902-36F6FFF8-666E-4D37-B3A6-95DBFC039B4DQ34588754-39D91051-C971-48FB-9CBE-A52DFECF1083Q34831072-BCA08926-CA81-43A1-B34D-2E6C36A35166Q34998108-EB6023C2-2D24-4A0C-AD24-B91790BA2A69Q35078337-70754EFF-5606-483F-9A2B-7E6CCEA64451Q35542640-34EDB6BD-EB92-4DD1-935B-1872CD3CECBBQ35555687-FCC40283-75C9-4C31-8915-CDB91694597DQ36108499-8CE97C34-9DFC-4FE4-9742-860446F70B72Q36220440-F857CD88-48EF-4309-8434-61D4183F3B2CQ36404946-1AB74DA6-03EB-4E0E-9A00-EE90AED15C88Q36589416-2A70D009-976E-433E-8B98-6F452187DE33Q37162458-B7A06BD8-8B8F-4FA0-9A33-DC45E162A31AQ38049779-11BF3547-C519-4024-9E92-62D6E723C8F9Q38185703-F732535C-52EF-4723-9345-2A6EC0F9F101Q38204130-3ED27C31-F1BB-4359-9D3C-2B76AE606E5BQ38230162-381234EA-2453-4D40-96EA-7C561C416305Q38258954-E71019ED-E3AF-490F-B7FF-9D8E98315AC9Q38442953-687307F1-46B1-45B7-B1DA-E32825642163Q38552422-C29F805F-65EA-4019-8A59-2DE5FA90B41CQ39906288-76680606-FD03-41CA-AC94-7B4F2DBF09CDQ39975422-BC3C03B6-65AC-4829-8C67-4AAE86A0EE48Q41684197-2B045112-1CCE-4DD9-84ED-B73EE07F2294Q41696055-E3E86F41-375F-4CDB-8188-1132ADBB7DE5Q42528303-B99BFF94-1C96-4B9A-9420-BAAC66925B58Q42674728-2F0C2A2F-BB5C-4FDD-83A2-2132A72A0E23Q43127800-902BF50A-07B3-4A2D-A124-4F237D3E19E3Q43214835-7D9E02A4-34E2-4625-A93E-DC93CDDCF944Q43353488-041B7CE9-8551-4155-ACDB-147A2F1EE20FQ43363077-CC3A559A-3BA4-47C6-A708-0B28D2B193EBQ43442244-26A0C669-BA0C-4A8C-8462-67E37608B607Q43606551-893A83AB-9F57-459F-BDE5-CCCB667BF7D7Q43659057-3B8681E1-778D-499B-99AF-141B2448D70AQ43738965-0E05423E-17E2-4784-88EA-D5E46009C488
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Gionchetti
@ast
Paolo Gionchetti
@en
Paolo Gionchetti
@es
Paolo Gionchetti
@nl
type
label
Paolo Gionchetti
@ast
Paolo Gionchetti
@en
Paolo Gionchetti
@es
Paolo Gionchetti
@nl
prefLabel
Paolo Gionchetti
@ast
Paolo Gionchetti
@en
Paolo Gionchetti
@es
Paolo Gionchetti
@nl
P106
P1153
7005431799
P31
P496
0000-0001-9479-5307